Anterior segment recurrence of acute myelogenous leukemia: treatment with subconjunctival injections of methotrexate and triamcinolone acetonide

Can J Ophthalmol. 1997 Jun;32(4):265-7.

Authors

S E Katz¹, N K Wade, D P Anderson, J Rootman

Affiliation

¹ Department of Ophthalmology, St Paul's Hospital, Vancouver, BC.

PMID: 9199837

No abstract available

Publication types

Case Reports

MeSH terms

Anterior Eye Segment / pathology*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biopsy, Needle
Conjunctiva
Fatal Outcome
Glucocorticoids / administration & dosage
Glucocorticoids / therapeutic use*
Humans
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / therapeutic use*
Injections
Leukemia, Myeloid, Acute / diagnosis
Leukemia, Myeloid, Acute / drug therapy*
Male
Methotrexate / administration & dosage
Methotrexate / therapeutic use*
Middle Aged
Neoplasm Recurrence, Local / diagnosis
Neoplasm Recurrence, Local / drug therapy*
Tomography, X-Ray Computed
Triamcinolone / administration & dosage
Triamcinolone / therapeutic use*

Substances

Glucocorticoids
Immunosuppressive Agents
Triamcinolone
Methotrexate